The Association for
Mass Spectrometry & Advances in the Clinical Lab
MSACL is committed to the advancement of mass spectrometry and other advanced technologies, including data science, in the clinical laboratory through education and training of practitioners, physicians, laboratory scientists, industrial scientists, and health care professionals involved in patient care and management. MSACL supports the development of new technologies to be used in laboratory medicine; including diagnosis, treatment, and prognosis of clinical disorders.
MSACL was incorporated in May 2009 as non-profit and is tax exempt under 501(c)(3). The association's mission is to further the accumulation and sharing of expertise in the area of mass spectrometry and advanced technologies for use in the clinical laboratory with the goal of improving patient care. As part of this mission the association hosts MSACL conferences in the US and Europe, as well as supporting educational activities in Asia. MSACL also supports and manages the society's Journal of Mass Spectrometry & Advances in the Clinical Lab.
The objective of MSACL is to support the enhancement of patient care using technology & data science. The target audience includes pathologists, clinical laboratory directors, clinical scientists, and researchers, as well as laboratory diagnostic providers. This programs provided by MSACL are beneficial to healthcare administrators, laboratory quality control and standards scientists, as well as those responsible for implementation of clinical analyses for emergency response due to terrorism or accident.
MSACL conference attendees include individuals interested in the educational, medical, scientific, economic, and regulatory aspects of the applications of mass spectrometry in the clinical laboratory. These individuals include pathologists, clinical laboratory scientists, clinicians, government employees - especially those involved in regulation of the field - and professionals in the in vitro diagnostics industry.
MSACL attendees are involved in all aspects of clinical analysis: performance, interpretation, reporting of diagnostic tests, assay development and validation, and medical education. Many members participate in research aimed at broadening the understanding of disease processes, and developing new technologies. MSACL aims to inform and educate its members as well as other professionals interested in mass spectrometry and other advanced technologies through its annual meeting, journal and website.